The United Health Foundation to Provide $1M to Support Relief Efforts in Ukraine

The United Health Foundation, the philanthropic foundation of UnitedHealth Group (NYSE: UNH), today announced a $1 million donation to support relief efforts in Ukraine.

The United Health Foundation donation includes:

  • $500,000 to Save the Children, the U.S. affiliate of Save the Children International, to support its Ukraine Crisis Relief Fund to provide children and families with immediate aid such as food, water, hygiene kits and psychosocial support.
  • $500,0000 to Direct Relief, a long-standing United Health Foundation partner on disaster response, to provide emergency medical supplies including critical care medicines, oxygen concentrators, antibiotics and other medical equipment to the Ukrainian Ministry of Health.

“We share deep concern for people in Ukraine amid this humanitarian crisis,” said Patricia Lewis, UnitedHealth Group chief sustainability officer. “This donation will help provide immediate support to families in need, and we’re grateful for the work of both Save the Children and Direct Relief.”

Save the Children has worked in Ukraine since 2014 and is working closely with its Ukrainian affiliate and local partners, while Direct Relief is building on the $26 million in support it has provided to Ukraine over the last six months as part of broader medical aid efforts.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.